Effect of a minimal pharmacy intervention on improvement of adherence to asthma guidelines

Tjalling W de Vries1, Paul B van den Berg, Eric J Duiverman

  • 1Department of Paediatrics, Medical Centre Leeuwarden, PO Box 888, 8901 BR Leeuwarden, The Netherlands. tjalling.de.vries@znb.nl

Insights

Pharmacist intervention improved adherence to paediatric asthma guidelines. This minimal strategy, involving discussions with general practitioners, led to better medication use in children with asthma.

Area of Science:

  • Pediatric Pulmonology
  • Evidence-Based Medicine
  • Community Pharmacy Practice

Background:

  • Asthma management in children requires adherence to established clinical guidelines.
  • Suboptimal adherence to paediatric asthma guidelines can lead to poor disease control and increased healthcare utilization.
  • Community pharmacists are well-positioned to support guideline adherence through collaboration with general practitioners.

Purpose of the Study:

  • To evaluate the effectiveness of a minimal intervention strategy involving community pharmacists in improving adherence to paediatric asthma guidelines.
  • To assess the impact of pharmacist-led discussions on prescribing patterns for children with asthma.

Main Methods:

  • A comparative study design was employed, involving an intervention group (pharmacies collaborating with general practitioners) and a reference group (non-participating pharmacies).
  • Adherence to paediatric asthma guidelines was assessed by analyzing prescription data for children with asthma.
  • Key outcome measures included the proportion of children without short-acting beta-mimetic use, those without inhaled corticosteroids despite long-acting beta-mimetic use, and those prescribed more than one inhaler type.

Main Results:

  • The intervention group showed a significantly lower number of children without short-acting beta-mimetic prescriptions (p<0.01).
  • Fewer children in the intervention group were prescribed long-acting beta-mimetic without inhaled corticosteroids (p=0.03).
  • While the rate of using more than one inhaler type was similar between groups, it was significantly lower compared to a previous study (p<0.01).

Conclusions:

  • Community pharmacist involvement in discussing paediatric asthma care elements with general practitioners is beneficial for guideline adherence.
  • Active engagement of pharmacists in paediatric asthma care can lead to improved prescribing practices and potentially better patient outcomes.
  • This study highlights the value of minimal pharmacist interventions in optimizing the management of childhood asthma.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...